[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

VPAResearch: Market Research Reports

VPA Research is one of the global pharmaceutical companies specialized in analysis of clinical trials. We provide leading insights into global Pharma products, pipeline research, companies and drugs markets.

Publications found: 58,333
Sort by:

2019 Myeloid Metaplasia Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Myeloid Metaplasia Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Myeloid Metaplasia. It presents in-depth analysis of Myeloid Metaplasia clinical trials across markets and companies ...

April 2019 227 pages

2019 Myelopathy Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Myelopathy Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Myelopathy. It presents in-depth analysis of Myelopathy clinical trials across markets and companies ...

April 2019 65 pages

2019 Myocardial Ischemia Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Myocardial Ischemia Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Myocardial Ischemia. It presents in-depth analysis of Myocardial Ischemia clinical trials across markets and companies ...

April 2019 310 pages

2019 Myoclonic Seizure Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Myoclonic Seizure Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Myoclonic Seizure. It presents in-depth analysis of Myoclonic Seizure clinical trials across markets and companies ...

April 2019 120 pages

2019 Myopia Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Myopia Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Myopia. It presents in-depth analysis of Myopia clinical trials across markets and companies ...

April 2019 130 pages

2019 Myxoid Liposarcoma Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Myxoid Liposarcoma Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Myxoid Liposarcoma. It presents in-depth analysis of Myxoid Liposarcoma clinical trials across markets and companies ...

April 2019 49 pages

2019 Narcolepsy Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Narcolepsy Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Narcolepsy. It presents in-depth analysis of Narcolepsy clinical trials across markets and companies ...

April 2019 70 pages

2019 Nasal Congestion Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Nasal Congestion Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Nasal Congestion. It presents in-depth analysis of Nasal Congestion clinical trials across markets and companies ...

April 2019 62 pages

2019 Nasal Obstruction Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Nasal Obstruction Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Nasal Obstruction. It presents in-depth analysis of Nasal Obstruction clinical trials across markets and companies ...

April 2019 56 pages

2019 Nasal Polyposis Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Nasal Polyposis Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Nasal Polyposis. It presents in-depth analysis of Nasal Polyposis clinical trials across markets and companies ...

April 2019 113 pages

2019 Nasal Polyps Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Nasal Polyps Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Nasal Polyps. It presents in-depth analysis of Nasal Polyps clinical trials across markets and companies ...

April 2019 110 pages

2019 Nasopharyngeal Cancer Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Nasopharyngeal Cancer Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Nasopharyngeal Cancer. It presents in-depth analysis of Nasopharyngeal Cancer clinical trials across markets and companies ...

April 2019 272 pages

2019 Natural Killer Cell Lymphomas Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

... report- “2019 Natural Killer Cell Lymphomas Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Natural Killer Cell Lymphomas. It presents in-depth analysis of Natural Killer Cell Lymphomas clinical trials ...

April 2019 112 pages

2019 Neck Pain Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Neck Pain Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Neck Pain. It presents in-depth analysis of Neck Pain clinical trials across markets and companies ...

April 2019 100 pages

2019 Neisseria meningitidis Infections Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Neisseria meningitidis Infections Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Neisseria meningitidis Infections. It presents in-depth analysis of Neisseria meningitidis Infections clinical trials ...

April 2019 292 pages

2019 Neonatal Respiratory Distress Syndrome Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

... report- “2019 Neonatal Respiratory Distress Syndrome Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Neonatal Respiratory Distress Syndrome. It presents in-depth analysis of Neonatal Respiratory Distress Syndrome clinical trials ...

April 2019 115 pages

2019 Neonatal Seizures Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Neonatal Seizures Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Neonatal Seizures. It presents in-depth analysis of Neonatal Seizures clinical trials across markets and companies ...

April 2019 47 pages

2019 Neoplastic Syndrome Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Neoplastic Syndrome Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Neoplastic Syndrome. It presents in-depth analysis of Neoplastic Syndrome clinical trials across markets and companies ...

April 2019 54 pages

2019 Neovascular Glaucoma Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Neovascular Glaucoma Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Neovascular Glaucoma. It presents in-depth analysis of Neovascular Glaucoma clinical trials across markets and companies ...

April 2019 48 pages

2019 Nephrotic Syndrome Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Nephrotic Syndrome Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Nephrotic Syndrome. It presents in-depth analysis of Nephrotic Syndrome clinical trials across markets and companies ...

April 2019 102 pages

2019 Neuroblastoma Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Neuroblastoma Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Neuroblastoma. It presents in-depth analysis of Neuroblastoma clinical trials across markets and companies ...

April 2019 238 pages

2019 Neuroendocrine Carcinoma Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Neuroendocrine Carcinoma Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Neuroendocrine Carcinoma. It presents in-depth analysis of Neuroendocrine Carcinoma clinical trials across markets and companies ...

April 2019 159 pages

2019 Neurofibromatoses Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Neurofibromatoses Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Neurofibromatoses. It presents in-depth analysis of Neurofibromatoses clinical trials across markets and companies ...

April 2019 159 pages

2019 Neurofibromatoses Type I (Von Recklinghausen’s Disease) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

... trial report- “2019 Neurofibromatoses Type I (Von Recklinghausen’s Disease) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Neurofibromatoses Type I (Von Recklinghausen’s Disease ...

April 2019 118 pages

2019 Neuromyelitis Optica (Devic’s Syndrome) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

... report- “2019 Neuromyelitis Optica (Devic’s Syndrome) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Neuromyelitis Optica (Devic’s Syndrome). It presents in-depth analysis of Neuromyelitis Optica (Devic’s Syndrome) clinical trials ...

April 2019 60 pages

2019 Neurotoxicity Syndromes Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Neurotoxicity Syndromes Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Neurotoxicity Syndromes. It presents in-depth analysis of Neurotoxicity Syndromes clinical trials across markets and companies ...

April 2019 116 pages

2019 Neutropenia Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Neutropenia Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Neutropenia. It presents in-depth analysis of Neutropenia clinical trials across markets and companies ...

April 2019 219 pages

2019 Nicotine Addiction Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Nicotine Addiction Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Nicotine Addiction. It presents in-depth analysis of Nicotine Addiction clinical trials across markets and companies ...

April 2019 243 pages

2019 Nocturia Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Nocturia Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Nocturia. It presents in-depth analysis of Nocturia clinical trials across markets and companies ...

April 2019 81 pages

2019 Nocturnal Enuresis Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Nocturnal Enuresis Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Nocturnal Enuresis. It presents in-depth analysis of Nocturnal Enuresis clinical trials across markets and companies ...

April 2019 72 pages

2019 Non Alcoholic Fatty Liver Disease (NAFLD) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

... trial report- “2019 Non Alcoholic Fatty Liver Disease (NAFLD) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Non Alcoholic Fatty Liver Disease (NAFLD ...

April 2019 344 pages

2019 Non Malignant pain Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Non Malignant pain Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Non Malignant pain. It presents in-depth analysis of Non Malignant pain clinical trials ...

April 2019 58 pages

2019 Non-Alcoholic Steatohepatitis (NASH) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Non-Alcoholic Steatohepatitis (NASH) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Non-Alcoholic Steatohepatitis (NASH). It presents in-depth analysis of Non-Alcoholic Steatohepatitis (NASH) clinical trials ...

April 2019 331 pages

2019 Nonerosive Reflux Disease (NERD) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

... report- “2019 Nonerosive Reflux Disease (NERD) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Nonerosive Reflux Disease (NERD). It presents in-depth analysis of Nonerosive Reflux Disease (NERD) clinical trials ...

April 2019 64 pages

2019 Non-ischemic Cardiomyopathy Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Non-ischemic Cardiomyopathy Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Non-ischemic Cardiomyopathy. It presents in-depth analysis of Non-ischemic Cardiomyopathy clinical trials across markets and companies ...

April 2019 46 pages

2019 Non-Proliferative Diabetic Retinopathy (NPDR) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

... report- “2019 Non-Proliferative Diabetic Retinopathy (NPDR) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Non-Proliferative Diabetic Retinopathy (NPDR). It presents in-depth analysis of Non-Proliferative Diabetic Retinopathy (NPDR) clinical trials ...

April 2019 57 pages

2019 Non-Rhabdomyosarcoma Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Non-Rhabdomyosarcoma Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Non-Rhabdomyosarcoma. It presents in-depth analysis of Non-Rhabdomyosarcoma clinical trials across markets and companies ...

April 2019 198 pages

2019 Nonseminomatous Testicular Cancer Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Nonseminomatous Testicular Cancer Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Nonseminomatous Testicular Cancer. It presents in-depth analysis of Nonseminomatous Testicular Cancer clinical trials ...

April 2019 44 pages

2019 Normal-Tension Glaucoma Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Normal-Tension Glaucoma Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Normal-Tension Glaucoma. It presents in-depth analysis of Normal-Tension Glaucoma clinical trials across markets and companies ...

April 2019 46 pages

2019 Obsessive Compulsive Disorder Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Obsessive Compulsive Disorder Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Obsessive Compulsive Disorder. It presents in-depth analysis of Obsessive Compulsive Disorder clinical trials ...

April 2019 122 pages

2019 Obstructive Sleep Apnea Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Obstructive Sleep Apnea Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Obstructive Sleep Apnea. It presents in-depth analysis of Obstructive Sleep Apnea clinical trials ...

April 2019 250 pages

2019 Occlusive Coronary Artery Disease Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

... report- “2019 Occlusive Coronary Artery Disease Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Occlusive Coronary Artery Disease. It presents in-depth analysis of Occlusive Coronary Artery Disease clinical trials ...

April 2019 46 pages

2019 Ocular Hypertension Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Ocular Hypertension Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Ocular Hypertension. It presents in-depth analysis of Ocular Hypertension clinical trials across markets and companies ...

April 2019 491 pages

2019 Ocular Melanoma Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Ocular Melanoma Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Ocular Melanoma. It presents in-depth analysis of Ocular Melanoma clinical trials across markets and companies ...

April 2019 60 pages

2019 Ocular Pain Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Ocular Pain Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Ocular Pain. It presents in-depth analysis of Ocular Pain clinical trials across markets and companies ...

April 2019 108 pages

2019 Olfactory Disorders Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Olfactory Disorders Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Olfactory Disorders. It presents in-depth analysis of Olfactory Disorders clinical trials across markets and companies ...

April 2019 43 pages

2019 Oligodendroglioma Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Oligodendroglioma Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Oligodendroglioma. It presents in-depth analysis of Oligodendroglioma clinical trials across markets and companies ...

April 2019 264 pages

2019 Oligozoospermia Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Oligozoospermia Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Oligozoospermia. It presents in-depth analysis of Oligozoospermia clinical trials across markets and companies ...

April 2019 49 pages

2019 Onchocerciasis (River Blindness) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Onchocerciasis (River Blindness) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Onchocerciasis (River Blindness). It presents in-depth analysis of Onchocerciasis (River Blindness) clinical trials ...

April 2019 47 pages

2019 Onychomycosis (Tinea Unguium) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Onychomycosis (Tinea Unguium) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Onychomycosis (Tinea Unguium). It presents in-depth analysis of Onychomycosis (Tinea Unguium) clinical trials ...

April 2019 94 pages

Filters

Search

Categories

60
12,968
1,223
4,429
2
1
10,890
2,818
15,138
67
8,921
1
1,229
586

Publishers

58,333

Regions

1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
58,296

Price

Date

Pages

Offers